Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

May-19

AUTHORS : Prof William Alazawi, Blizard Institute, Barts and The London School of Medicine and Dentistry, The Blizard Building, 4 Newark Street, London E1 2AT, UK – Email: w.alazawi@qmul.ac.uk – Profile: https://www.qmul.ac.uk/blizard/all-staff/profiles/william-alazawi.html

JOURNAL : BMC Medicine

REFERENCE: 17(1):95

DOI : 10.1186/s12916-019-1321-x

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

More publications

Evaluating the potential impact of lifestyle‑based behavior change interventions delivered at the time of colorectal cancer screening

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions

Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin